Cargando…
Primary Central Nervous System Lymphomatoid Granulomatosis: Systemic Review
Lymphomatoid granulomatosis (LYG) is an infrequent lymphoproliferative disease that typically involves the lungs, but may also affect the central nervous system (CNS). Isolated CNS involvement is very rare, and its clinicopathological features have not been fully elucidated. Here, we systematically...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516720/ https://www.ncbi.nlm.nih.gov/pubmed/33041962 http://dx.doi.org/10.3389/fneur.2020.00901 |
_version_ | 1783587066283556864 |
---|---|
author | Xiang, Yuanyuan Liu, Cuicui Xue, Yuan Li, Shan Sui, Yanling Li, Jifeng Sun, Qinjian Liu, Xiaohui |
author_facet | Xiang, Yuanyuan Liu, Cuicui Xue, Yuan Li, Shan Sui, Yanling Li, Jifeng Sun, Qinjian Liu, Xiaohui |
author_sort | Xiang, Yuanyuan |
collection | PubMed |
description | Lymphomatoid granulomatosis (LYG) is an infrequent lymphoproliferative disease that typically involves the lungs, but may also affect the central nervous system (CNS). Isolated CNS involvement is very rare, and its clinicopathological features have not been fully elucidated. Here, we systematically reviewed the English literature through PubMed to collect all relevant case reports and small case series with pathologically confirmed primary CNS-LYG. A total of 29 relevant articles with 40 cases were included in this systemic review. In cases where T cells and B cells were compared, T cells were predominant in 19 (79.2%), and B cells were predominant in 5 (20.8%). The overall infection rate of EBV was 48.1% (13/27), among which the infection rate was 40.9% (9/22) in immunocompetent patients and 80% (4/5) in immunodeficient (HIV-infected) patients. Among the patients who underwent pathological grading, 35.7% (5/14) were at grade I, 42.9% (6/14) were at grade II, and 21.4% were at grade III. In conclusion, primary CNS-LYG is closely related to EBV infection and some cases may be predominantly T-cell phenotype. Surgical resection may be effective for mass-like lesions, although there is still a lack of standard therapeutic regimen. Accurate grading of lesions is essential for treatment selection and prognosis evaluation. |
format | Online Article Text |
id | pubmed-7516720 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75167202020-10-09 Primary Central Nervous System Lymphomatoid Granulomatosis: Systemic Review Xiang, Yuanyuan Liu, Cuicui Xue, Yuan Li, Shan Sui, Yanling Li, Jifeng Sun, Qinjian Liu, Xiaohui Front Neurol Neurology Lymphomatoid granulomatosis (LYG) is an infrequent lymphoproliferative disease that typically involves the lungs, but may also affect the central nervous system (CNS). Isolated CNS involvement is very rare, and its clinicopathological features have not been fully elucidated. Here, we systematically reviewed the English literature through PubMed to collect all relevant case reports and small case series with pathologically confirmed primary CNS-LYG. A total of 29 relevant articles with 40 cases were included in this systemic review. In cases where T cells and B cells were compared, T cells were predominant in 19 (79.2%), and B cells were predominant in 5 (20.8%). The overall infection rate of EBV was 48.1% (13/27), among which the infection rate was 40.9% (9/22) in immunocompetent patients and 80% (4/5) in immunodeficient (HIV-infected) patients. Among the patients who underwent pathological grading, 35.7% (5/14) were at grade I, 42.9% (6/14) were at grade II, and 21.4% were at grade III. In conclusion, primary CNS-LYG is closely related to EBV infection and some cases may be predominantly T-cell phenotype. Surgical resection may be effective for mass-like lesions, although there is still a lack of standard therapeutic regimen. Accurate grading of lesions is essential for treatment selection and prognosis evaluation. Frontiers Media S.A. 2020-09-11 /pmc/articles/PMC7516720/ /pubmed/33041962 http://dx.doi.org/10.3389/fneur.2020.00901 Text en Copyright © 2020 Xiang, Liu, Xue, Li, Sui, Li, Sun and Liu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Xiang, Yuanyuan Liu, Cuicui Xue, Yuan Li, Shan Sui, Yanling Li, Jifeng Sun, Qinjian Liu, Xiaohui Primary Central Nervous System Lymphomatoid Granulomatosis: Systemic Review |
title | Primary Central Nervous System Lymphomatoid Granulomatosis: Systemic Review |
title_full | Primary Central Nervous System Lymphomatoid Granulomatosis: Systemic Review |
title_fullStr | Primary Central Nervous System Lymphomatoid Granulomatosis: Systemic Review |
title_full_unstemmed | Primary Central Nervous System Lymphomatoid Granulomatosis: Systemic Review |
title_short | Primary Central Nervous System Lymphomatoid Granulomatosis: Systemic Review |
title_sort | primary central nervous system lymphomatoid granulomatosis: systemic review |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516720/ https://www.ncbi.nlm.nih.gov/pubmed/33041962 http://dx.doi.org/10.3389/fneur.2020.00901 |
work_keys_str_mv | AT xiangyuanyuan primarycentralnervoussystemlymphomatoidgranulomatosissystemicreview AT liucuicui primarycentralnervoussystemlymphomatoidgranulomatosissystemicreview AT xueyuan primarycentralnervoussystemlymphomatoidgranulomatosissystemicreview AT lishan primarycentralnervoussystemlymphomatoidgranulomatosissystemicreview AT suiyanling primarycentralnervoussystemlymphomatoidgranulomatosissystemicreview AT lijifeng primarycentralnervoussystemlymphomatoidgranulomatosissystemicreview AT sunqinjian primarycentralnervoussystemlymphomatoidgranulomatosissystemicreview AT liuxiaohui primarycentralnervoussystemlymphomatoidgranulomatosissystemicreview |